Patients with Biallelic BRCA1/2 Inactivation Respond to Olaparib Treatment Across Histologic Tumor Types

Find Full text
Thumbnail
Fulltext:
241126.pdf
Embargo:
until further notice
Size:
370.0Kb
Format:
PDF
Description:
Publisher’s version
Publication year
2021
Author(s)
Wijngaart, H. van der
Hoes, L.R.
Berge Henegouwen, J.M. van
Velden, D. L. van der
Zeverijn, Laurien J.
Roepman, P.
Mehra, N.
Voest, E.E.
Verheul, H.M.W.
Source
Clinical Cancer Research, 27, 22, (2021), pp. 6106-6114
ISSN
DOI
Publication type
Article / Letter to editor
If a DOI or any other persistent identifier is unavailable, please use the following repository identifier to link to this item: https://hdl.handle.net/2066/241126   https://hdl.handle.net/2066/241126
Display more details

Upload full text

Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.